Chromone derivatives useful as vanilloid antagonists

Details for Australian Patent Application No. 2005251920 (hide)

Owner Novartis AG

Inventors Ritchie, Timothy John; Dziadulewicz, Edward Karol; Culshaw, Andrew James; Hart, Terance William; Brain, Christopher Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2005251920

PCT Pub. Number WO2005/121116

Priority 0412768.4 08.06.04 GB

Filing date 8 June 2005

Wipo publication date 22 December 2005

International Classifications

C07D 311/36 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/121116 Priority application(s): WO2005/121116

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251923-4-phenyl-pyrimidine-2-carbonitrile derivatives

2005251919-Roller bearing in a roller press